 |
 |
 |
 |
 |
 |
  |
|
|
|
|
|
|
|
|
|
| Founded
in 1994, as a research extension of Endocrine
Associates of Dallas, P.A., the Research Institute of Dallas, P.A. was established to conduct
clinical trials and to provide the highest quality of service to
both sponsors and patients.
Research
Institute of Dallas is operated by the physicians
of Endocrine Associates of Dallas and is committed to developing
and maintaining the finest research site available in the Metroplex. The Institute endeavor is to be a key player in the continuous effort to develop new standards in today changing health care industry. Dallas population demographics provide our facility with the ability to demonstrate successful recruitment for ongoing studies at the highest level. Our research expertise and experience in Endocrinology provide many advantages to our clinical trial participation. Being associated with the physician private practice allows for rapid enrollment in studies. Our physician comprehensive, as well as, extensive knowledge assures the highest quality of medical care for our patients and the validity of clinical data to our sponsors. Research Institute of Dallas welcomes the opportunity to develop a long lasting and beneficial relationship with you in the clinical research arena. |
| Director Stephen Aronoff, M.D., F.A.C.P., F.A.C.E. Medical Board |
| The mission of Research Institute of Dallas, P.A. is to provide the clinical research industry with a facility that continuously strives to conduct cost efficient Phase II - IV clinical trials while demonstrating integrity and compassion for our patients. |